2000

May 17, 2000
Guidant Announces Settlement Structure for Patent Litigation

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world-leader in the treatment of cardiovascular disease, announced today that it has agreed with Boston Scientific Corporation on a...

May 16, 2000
Guidant Launches Clinical Trial to Study Carotid Artery Stenting as a Stroke Prevention Alternative for High-Risk Patients

Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT), a global leader in the development of technologies for the treatment of carotid artery and peripheral vascular...

May 15, 2000
Guidant Launches its Fourth-Generation Coronary Stent System

MULTI-LINK TETRA Coronary Stent System Receives CE Mark Approval Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery...

May 9, 2000
Guidant Corporation Announces CE Mark and Launch of its GALILEO System, A Beta-Radiation Treatment for Coronary Artery Disease

Indianapolis, IN and Santa Clara, CA - Patients suffering from re-occurring blockages in coronary arteries can now look forward to a new technology that has been shown to reduce the recurrence of...

Apr 25, 2000
Guidant Announces Start of PACMAN Study To Further Evaluate Novel Heart Failure Treatment

Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced the start of PACMAN, a multicenter European...

Show 5102550100 per page
Top